Highlights
The global PCR-Based Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for PCR-Based Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PCR-Based Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for PCR-Based Testing in Diagnosis and Treatment is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of PCR-Based Testing include Abbott, Bio-Rad, Bosch Healthcare, GenMark Diagnostics, GSK, Roche, MeMed, Micronics (Sony) and Qorvo Biotechnologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PCR-Based Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR-Based Testing.
The PCR-Based Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PCR-Based Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PCR-Based Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott
Bio-Rad
Bosch Healthcare
GenMark Diagnostics
GSK
Roche
MeMed
Micronics (Sony)
Qorvo Biotechnologies
Siemens Healthineers
STMicroelectronics
Veredus Laboratories
Zoetis
Thermo Fisher
QIAGEN
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
Segment by Type
Analyzers/Instruments
Kits/Panels
Segment by Application
Diagnosis and Treatment
Genetic Testing
Cancer
Evolutionary Biology
Genetic Fingerprint
Forensic Research
COVID-19
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PCR-Based Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR-Based Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Analyzers/Instruments
1.2.3 Kits/Panels
1.3 Market by Application
1.3.1 Global PCR-Based Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnosis and Treatment
1.3.3 Genetic Testing
1.3.4 Cancer
1.3.5 Evolutionary Biology
1.3.6 Genetic Fingerprint
1.3.7 Forensic Research
1.3.8 COVID-19
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR-Based Testing Market Perspective (2018-2029)
2.2 PCR-Based Testing Growth Trends by Region
2.2.1 Global PCR-Based Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 PCR-Based Testing Historic Market Size by Region (2018-2023)
2.2.3 PCR-Based Testing Forecasted Market Size by Region (2024-2029)
2.3 PCR-Based Testing Market Dynamics
2.3.1 PCR-Based Testing Industry Trends
2.3.2 PCR-Based Testing Market Drivers
2.3.3 PCR-Based Testing Market Challenges
2.3.4 PCR-Based Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR-Based Testing Players by Revenue
3.1.1 Global Top PCR-Based Testing Players by Revenue (2018-2023)
3.1.2 Global PCR-Based Testing Revenue Market Share by Players (2018-2023)
3.2 Global PCR-Based Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR-Based Testing Revenue
3.4 Global PCR-Based Testing Market Concentration Ratio
3.4.1 Global PCR-Based Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR-Based Testing Revenue in 2022
3.5 PCR-Based Testing Key Players Head office and Area Served
3.6 Key Players PCR-Based Testing Product Solution and Service
3.7 Date of Enter into PCR-Based Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR-Based Testing Breakdown Data by Type
4.1 Global PCR-Based Testing Historic Market Size by Type (2018-2023)
4.2 Global PCR-Based Testing Forecasted Market Size by Type (2024-2029)
5 PCR-Based Testing Breakdown Data by Application
5.1 Global PCR-Based Testing Historic Market Size by Application (2018-2023)
5.2 Global PCR-Based Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America PCR-Based Testing Market Size (2018-2029)
6.2 North America PCR-Based Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America PCR-Based Testing Market Size by Country (2018-2023)
6.4 North America PCR-Based Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PCR-Based Testing Market Size (2018-2029)
7.2 Europe PCR-Based Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe PCR-Based Testing Market Size by Country (2018-2023)
7.4 Europe PCR-Based Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR-Based Testing Market Size (2018-2029)
8.2 Asia-Pacific PCR-Based Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific PCR-Based Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific PCR-Based Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PCR-Based Testing Market Size (2018-2029)
9.2 Latin America PCR-Based Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America PCR-Based Testing Market Size by Country (2018-2023)
9.4 Latin America PCR-Based Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR-Based Testing Market Size (2018-2029)
10.2 Middle East & Africa PCR-Based Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa PCR-Based Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa PCR-Based Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott PCR-Based Testing Introduction
11.1.4 Abbott Revenue in PCR-Based Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad PCR-Based Testing Introduction
11.2.4 Bio-Rad Revenue in PCR-Based Testing Business (2018-2023)
11.2.5 Bio-Rad Recent Development
11.3 Bosch Healthcare
11.3.1 Bosch Healthcare Company Detail
11.3.2 Bosch Healthcare Business Overview
11.3.3 Bosch Healthcare PCR-Based Testing Introduction
11.3.4 Bosch Healthcare Revenue in PCR-Based Testing Business (2018-2023)
11.3.5 Bosch Healthcare Recent Development
11.4 GenMark Diagnostics
11.4.1 GenMark Diagnostics Company Detail
11.4.2 GenMark Diagnostics Business Overview
11.4.3 GenMark Diagnostics PCR-Based Testing Introduction
11.4.4 GenMark Diagnostics Revenue in PCR-Based Testing Business (2018-2023)
11.4.5 GenMark Diagnostics Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK PCR-Based Testing Introduction
11.5.4 GSK Revenue in PCR-Based Testing Business (2018-2023)
11.5.5 GSK Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche PCR-Based Testing Introduction
11.6.4 Roche Revenue in PCR-Based Testing Business (2018-2023)
11.6.5 Roche Recent Development
11.7 MeMed
11.7.1 MeMed Company Detail
11.7.2 MeMed Business Overview
11.7.3 MeMed PCR-Based Testing Introduction
11.7.4 MeMed Revenue in PCR-Based Testing Business (2018-2023)
11.7.5 MeMed Recent Development
11.8 Micronics (Sony)
11.8.1 Micronics (Sony) Company Detail
11.8.2 Micronics (Sony) Business Overview
11.8.3 Micronics (Sony) PCR-Based Testing Introduction
11.8.4 Micronics (Sony) Revenue in PCR-Based Testing Business (2018-2023)
11.8.5 Micronics (Sony) Recent Development
11.9 Qorvo Biotechnologies
11.9.1 Qorvo Biotechnologies Company Detail
11.9.2 Qorvo Biotechnologies Business Overview
11.9.3 Qorvo Biotechnologies PCR-Based Testing Introduction
11.9.4 Qorvo Biotechnologies Revenue in PCR-Based Testing Business (2018-2023)
11.9.5 Qorvo Biotechnologies Recent Development
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Detail
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers PCR-Based Testing Introduction
11.10.4 Siemens Healthineers Revenue in PCR-Based Testing Business (2018-2023)
11.10.5 Siemens Healthineers Recent Development
11.11 STMicroelectronics
11.11.1 STMicroelectronics Company Detail
11.11.2 STMicroelectronics Business Overview
11.11.3 STMicroelectronics PCR-Based Testing Introduction
11.11.4 STMicroelectronics Revenue in PCR-Based Testing Business (2018-2023)
11.11.5 STMicroelectronics Recent Development
11.12 Veredus Laboratories
11.12.1 Veredus Laboratories Company Detail
11.12.2 Veredus Laboratories Business Overview
11.12.3 Veredus Laboratories PCR-Based Testing Introduction
11.12.4 Veredus Laboratories Revenue in PCR-Based Testing Business (2018-2023)
11.12.5 Veredus Laboratories Recent Development
11.13 Zoetis
11.13.1 Zoetis Company Detail
11.13.2 Zoetis Business Overview
11.13.3 Zoetis PCR-Based Testing Introduction
11.13.4 Zoetis Revenue in PCR-Based Testing Business (2018-2023)
11.13.5 Zoetis Recent Development
11.14 Thermo Fisher
11.14.1 Thermo Fisher Company Detail
11.14.2 Thermo Fisher Business Overview
11.14.3 Thermo Fisher PCR-Based Testing Introduction
11.14.4 Thermo Fisher Revenue in PCR-Based Testing Business (2018-2023)
11.14.5 Thermo Fisher Recent Development
11.15 QIAGEN
11.15.1 QIAGEN Company Detail
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN PCR-Based Testing Introduction
11.15.4 QIAGEN Revenue in PCR-Based Testing Business (2018-2023)
11.15.5 QIAGEN Recent Development
11.16 Agilent
11.16.1 Agilent Company Detail
11.16.2 Agilent Business Overview
11.16.3 Agilent PCR-Based Testing Introduction
11.16.4 Agilent Revenue in PCR-Based Testing Business (2018-2023)
11.16.5 Agilent Recent Development
11.17 Bioer
11.17.1 Bioer Company Detail
11.17.2 Bioer Business Overview
11.17.3 Bioer PCR-Based Testing Introduction
11.17.4 Bioer Revenue in PCR-Based Testing Business (2018-2023)
11.17.5 Bioer Recent Development
11.18 Biosynex
11.18.1 Biosynex Company Detail
11.18.2 Biosynex Business Overview
11.18.3 Biosynex PCR-Based Testing Introduction
11.18.4 Biosynex Revenue in PCR-Based Testing Business (2018-2023)
11.18.5 Biosynex Recent Development
11.19 Esco
11.19.1 Esco Company Detail
11.19.2 Esco Business Overview
11.19.3 Esco PCR-Based Testing Introduction
11.19.4 Esco Revenue in PCR-Based Testing Business (2018-2023)
11.19.5 Esco Recent Development
11.20 Analytik Jena
11.20.1 Analytik Jena Company Detail
11.20.2 Analytik Jena Business Overview
11.20.3 Analytik Jena PCR-Based Testing Introduction
11.20.4 Analytik Jena Revenue in PCR-Based Testing Business (2018-2023)
11.20.5 Analytik Jena Recent Development
11.21 Techne
11.21.1 Techne Company Detail
11.21.2 Techne Business Overview
11.21.3 Techne PCR-Based Testing Introduction
11.21.4 Techne Revenue in PCR-Based Testing Business (2018-2023)
11.21.5 Techne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott
Bio-Rad
Bosch Healthcare
GenMark Diagnostics
GSK
Roche
MeMed
Micronics (Sony)
Qorvo Biotechnologies
Siemens Healthineers
STMicroelectronics
Veredus Laboratories
Zoetis
Thermo Fisher
QIAGEN
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
听
听
*If Applicable.
